2.10
Investigación biofarmacéutica: aspectos esenciales de los estudios clínicos
Los estudios biofarmacéuticos constituyen un campo vital que apunta a mejorar los métodos de administración de medicamentos y refinar los enfoques ter…
Los estudios biofarmacéuticos tienen como objetivo estudiar la administración de fármacos y la mejora de las terapias utilizando el conocimiento interdisciplinario.
Los estudios no controlados, que a menudo se utilizan para la exploración inicial, carecen de un grupo de control, lo que puede dar lugar a sesgos e influencias externas.
Por el contrario, los estudios controlados emplean un grupo de control e incorporan técnicas como placebo, controles de tratamiento históricos, cruzados o estándar para reducir el sesgo.
Para minimizar aún más el sesgo, el enmascaramiento mantiene a los participantes o investigadores desinformados del tratamiento asignado. Esto incluye estudios ciego simple, doble ciego y doble simulacro.
Los factores de confusión, causados por variables externas que afectan el resultado del estudio, se mitigan mediante el diseño, la metodología y el análisis estadístico adecuados, y ayudan a validar el estudio.
La validez interna se refiere a la calidad de la ejecución del estudio, mientras que la validez externa mide la aplicabilidad de los hallazgos a otras poblaciones.
En los estudios clínicos, el cálculo del riesgo estima la asociación entre la exposición y el resultado. Abarca medidas como los riesgos absolutos y relativos, la reducción del riesgo absoluto y relativo, las cifras de tratamiento y la relación de peligros y probabilidades.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main difference between controlled and non-controlled biopharmaceutical studies?
Non-controlled studies lack a control group, making them susceptible to biases and external influences, though useful for initial exploration. Controlled studies employ control groups and techniques such as placebo, historical, crossover, or standard treatment controls to reduce bias and validate findings more rigorously.
Q2: How does blinding reduce bias in biopharmaceutical research?
Blinding keeps participants or investigators unaware of assigned treatments, preventing biased observations. Single-blind designs hide treatment from participants only, double-blind designs hide it from both participants and investigators, and double-dummy designs use placebos for one treatment while administering the active form of another to maintain blinding across different treatment types.
Q3: What role do confounding variables play in study validity?
Confounding variables are external factors that can affect study outcomes and compromise reliability. Proper study design, meticulous methodology, and statistical analysis mitigate confounding effects. Addressing confounding is essential for establishing internal validity, which assesses the quality of study execution and the experimental design's impact on results.
Q4: How do internal and external validity differ in biopharmaceutical studies?
Internal validity assesses the quality of study execution and how well the experimental design controls for bias and confounding. External validity gauges whether study findings apply to broader populations and real-world scenarios, ensuring research outcomes hold relevance beyond the immediate study group.
Q5: What measures are used to calculate risk in clinical biopharmaceutical studies?
Risk calculation estimates the exposure-outcome association using measures like absolute and relative risks, absolute and relative risk reduction, treatment numbers, and hazard and odds ratios. These calculations quantify risks associated with specific interventions, providing insights into treatment benefits and drawbacks to guide clinical decisions.
Q6: Why is statistical analysis important for addressing confounding in biopharmaceutical research?
Statistical analysis helps validate study findings by identifying and controlling for confounding variables that could distort results. Advanced statistical methods work alongside proper study design and methodology to isolate the true effect of treatments, strengthening the reliability of conclusions drawn from biopharmaceutical studies.
Q7: What interdisciplinary knowledge supports biopharmaceutical study design?
Biopharmaceutical studies integrate diverse fields to enhance drug delivery methods and refine therapeutic approaches. This interdisciplinary foundation informs the selection of appropriate study designs, control mechanisms, blinding techniques, and statistical methods needed to produce reliable, valid research that advances pharmaceutical science and patient care.